Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 12, 2011, Pages 2854-2860

  Agar, Baris U ^a   Akonur, Alp ^a   Lo, Ying Cheng ^a   Cheung, Alfred K ^b,c   Leypoldt, John K ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORUS; UREA;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DIALYSATE LEVEL; FEMALE; HEMODIALYSIS; HUMAN; KINETICS; LONG TERM CARE; MALE; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; REPRODUCIBILITY; UREA BLOOD LEVEL;

ADULT; AGED; CROSS-OVER STUDIES; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PHOSPHORUS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 83155172996     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03860411     Document Type: Article

References (40)

1. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458-482, 1990
2. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindberg J, Dreishbach A, Raggi P: Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68: 1815-1824, 2005
3. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12: 2131-2138, 2001
4. Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK: Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 52: 519-530, 2008
5. Covic A, Kothawala P, Bernal M, Robbins S, Chalian A, Goldsmith D: Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant 24: 1506-1523, 2009
6. Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H: Vascular calcification and inorganic phosphate. Am J Kidney Dis 38: S34-S37, 2001
7. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62: 245-252, 2002
8. Huang CX, Plantinga LC, Fink NE, Melamed ML, Coresh J, Powe NR: Phosphate levels and blood pressure in incident hemodialysis patients: A longitudinal study. Adv Chronic Kidney Dis 15: 321-331, 2008
9. Tonelli M, Pannu N, Manns B: Oral phosphate binders in patients with kidney failure. N Engl J Med 362: 1312-1324, 2010
10. Sherman RA, Mehta DO: Dietary phosphorus restriction in dialysis patients: Potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis 54: 19-23, 2009
11. Chauveau P, Poignet JL, Kuno T, Bonete R, Kerembrun A, Naret C, Delons S, Man NK, Rist E: Phosphate removal rate: A comparative study of five high-flux dialyzers. Nephrol Dial Transplant 6: 114-115, 1991
12. Mann NK, Chauveau P, Kuno T, Poignet JL, Yanai M: Phosphate removal during hemodialysis, hemodiafiltration, and hemofiltration. A reappraisal. ASAIO Trans 37: M463-M465, 1991
13. Lo A, Chin MM, Atkins RC: Dialyzer performance in the clinic: Comparison of six low-flux membranes. Artif Organs 23: 817-821, 1999
14. Penne EL, van der Weerd NC, van den Dorpel MA, Grooteman MPC, Lévesque R, Nubé MJ, Bots ML, Blankestijn PJ, ter Wee PM, on behalf of the CONTRAST Investigators: Shortterm effects of online hemodiafiltration on phosphate control: A result from the randomized controlled convective transport study (CONTRAST). Am J Kidney Dis 55: 77-87, 2009
15. Tonelli M, Wang W, Hemmelgarn B, Lloyd A, Manns B: Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients. Am J Kidney Dis 54: 1108-1115, 2009
16. Troidle L, Hotchkiss M, Finkelstein F: A thrice weekly in-center nocturnal hemodialysis program. Adv Chr Kidney Dis 14: 244-248, 2007
17. Bugeja A, Dacouris N, Thomas A, Marticorena R, McFarlane P, Donnelly S, Goldstein M: In-center nocturnal hemodialysis: another option in the management of chronic kidney disease. Clin J Am Soc Nephrol 4: 778-783, 2009
18. Musci I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53: 1399-1404, 1999
19. Ayus CJ, Mizani RM, Achinger SG, Thadhani R, Go AS, Lee S: Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J Am Soc Nephrol 16: 2778-2788, 2005
20. The FHN Trial Group: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363: 2287-2300, 2010
21. Sugasaki H, Onohara M, Kunitomo T: Dynamic behavior of plasma phosphate in chronic dialysis patients. Trans Am Soc Artif Intern Organs 28: 302-307, 1982
22. Sugasaki H, Onohara M, Kunitomo T: Phosphate in dialysis patients. Trans Am Soc Artif Intern Organs 29: 38-43, 1983
23. Heaf JG, Jensen SB, Jensen K, Ali S, von Jessen F: The cellular clearance theory does not explain the post-dialytic small molecule rebound. Scand J Urol Nephrol 32: 350-355, 1998
24. Spalding EM, Chamney PW, Farrington K: Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int 61: 655-667, 2002
25. Chen PS, Toribara TY, Warner H: Microdetermination of phosphorus. Anal Chem 28: 1756-1758, 1956
26. Lin L-K: A concordance correlation coefficient to evaluate reproducibility. Biometrics 45: 255-268, 1989
27. Lin L-K: A note on concordance correlation coefficient. Biometrics 45: 224-325, 2000
28. 2-microglobulin during and after short hemodialysis treatments. Kidney Int 66: 1669-1676, 2004
29. Pogglitsch H, Petek W, Ziak E, Sterz F, Holzer H: Phosphorus kinetics during haemodialysis and haemofiltration. Proc EDTA 21: 461-467, 1984
30. Desoi CA, Umans JG: Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol 4: 1214-1218, 1993
31. Haas T, Hillion D, Dongradi G: Phosphate kinetics in dialysis patients. Nephrol Dial Transplant Suppl 2: 108-113, 1991
32. Minutolo R, Bellizzi V, Cioffi M, Iodice C, Giannattasio P, Andreucci M: Postdialytic rebound of serum phosphorus: Pathogenetic and clinical insights. J Am Soc Nephrol 13: 1046-1054, 2002
33. Troidle L, Finkelstein F, Hotchkiss M, Leypoldt JK: Enhanced solute removal with intermittent, in-center, 8-hour nocturnal hemodialysis. Hemodial Int 13: 487-491, 2009
34. nd ed., edited by Davidson Am, Cameron JS, Grunfeld J-P, Kerr DNS, Ritz E, Oxford, Oxford Press, 1998, pp. 249-269
35. Gotch FA, Panlilio F, Sergeyeva O, Rosales L, Folden T, Kaysen G, Levin NW: A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif 21: 51-57, 2003
36. Heaf J, Jensen Simone: Normalized cellular clearance of creatinine, urea and phosphate. Nephron 67: 197-202, 1994
37. Katopodis KP, Chala A, Kolipousi E, Takouli L, Kalaitzidis R, Theodorou J, Siamopoulos: Role of dialyzer membrane on overall phosphate kinetics during hemodialysis. Blood Purif 23: 359-364, 2005
38. Hall JE: The body fluids and kidneys. In: Guyton and Hall Textbook of Medical Physiology, 12th ed., edited by Hall JE, Philadelphia PA, Saunders, 2011, pp. 285-301
39. 2-microglubulin removal by post-dilution hemodiafiltration. Kidney Int 69: 1431-1437, 2006
40. Ratanarat R, Brendolan A, Volker G, Bonello M, Salvatori G, Andrikos E, Yavuz A, Crepaldi C, Ronco C: Phosphate kinetics during different dialysis modalities. Blood Purif 23: 83-90, 2005